These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2. Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG mBio; 2020 Sep; 11(5):. PubMed ID: 32913009 [TBL] [Abstract][Full Text] [Related]
43. Advances in Next-Generation Coronavirus Vaccines in Response to Future Virus Evolution. Li L; Wei Y; Yang H; Yan J; Li X; Li Z; Zhao Y; Liang H; Wang H Vaccines (Basel); 2022 Nov; 10(12):. PubMed ID: 36560445 [TBL] [Abstract][Full Text] [Related]
44. Coinfections with Other Respiratory Pathogens among Patients with COVID-19. Sreenath K; Batra P; Vinayaraj EV; Bhatia R; SaiKiran K; Singh V; Singh S; Verma N; Singh UB; Mohan A; Bhatnagar S; Trikha A; Guleria R; Chaudhry R Microbiol Spectr; 2021 Sep; 9(1):e0016321. PubMed ID: 34287033 [TBL] [Abstract][Full Text] [Related]
46. Potential Drug Strategies to Target Coronaviruses. Sarkar K; Sil PC Adv Exp Med Biol; 2021; 1352():111-124. PubMed ID: 35132597 [TBL] [Abstract][Full Text] [Related]
47. The Integral Membrane Protein ZMPSTE24 Protects Cells from SARS-CoV-2 Spike-Mediated Pseudovirus Infection and Syncytia Formation. Shilagardi K; Spear ED; Abraham R; Griffin DE; Michaelis S mBio; 2022 Oct; 13(5):e0254322. PubMed ID: 36197088 [TBL] [Abstract][Full Text] [Related]
48. A systematic overview of metal nanoparticles as alternative disinfectants for emerging SARS-CoV-2 variants. Soni SK; Marya T; Sharma A; Thakur B; Soni R Arch Microbiol; 2024 Feb; 206(3):111. PubMed ID: 38372809 [TBL] [Abstract][Full Text] [Related]
49. Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past. Shah VK; Firmal P; Alam A; Ganguly D; Chattopadhyay S Front Immunol; 2020; 11():1949. PubMed ID: 32849654 [TBL] [Abstract][Full Text] [Related]
50. Travel-related control measures to contain the COVID-19 pandemic: a rapid review. Burns J; Movsisyan A; Stratil JM; Coenen M; Emmert-Fees KM; Geffert K; Hoffmann S; Horstick O; Laxy M; Pfadenhauer LM; von Philipsborn P; Sell K; Voss S; Rehfuess E Cochrane Database Syst Rev; 2020 Oct; 10():CD013717. PubMed ID: 33502002 [TBL] [Abstract][Full Text] [Related]
52. Multiple Sclerosis Disease-Modifying Therapy and the COVID-19 Pandemic: Implications on the Risk of Infection and Future Vaccination. Zheng C; Kar I; Chen CK; Sau C; Woodson S; Serra A; Abboud H CNS Drugs; 2020 Sep; 34(9):879-896. PubMed ID: 32780300 [TBL] [Abstract][Full Text] [Related]
53. Systematic Review of Clinical Insights into Novel Coronavirus (CoVID-19) Pandemic: Persisting Challenges in U.S. Rural Population. Lakhani HV; Pillai SS; Zehra M; Sharma I; Sodhi K Int J Environ Res Public Health; 2020 Jun; 17(12):. PubMed ID: 32549334 [TBL] [Abstract][Full Text] [Related]
54. Combating the Progression of Novel Coronavirus SARS-CoV-2 Infectious Disease: Current State and Future Prospects in Molecular Diagnostics and Drug Discovery. Kumar A; Sharma A; Tirpude NV; Thakur S; Kumar S Curr Mol Med; 2023; 23(2):127-146. PubMed ID: 34344288 [TBL] [Abstract][Full Text] [Related]
55. Recent Advances in N-Heterocycles for COVID-19 Treatment - A Mini Review. Dinodia M Med Chem; 2023; 19(8):717-729. PubMed ID: 36852805 [TBL] [Abstract][Full Text] [Related]
56. The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status. Bchetnia M; Girard C; Duchaine C; Laprise C J Infect Public Health; 2020 Nov; 13(11):1601-1610. PubMed ID: 32778421 [TBL] [Abstract][Full Text] [Related]
57. Plant-derived strategies to fight against severe acute respiratory syndrome coronavirus 2. Li W; Ding T; Chang H; Peng Y; Li J; Liang X; Ma H; Li F; Ren M; Wang W Eur J Med Chem; 2024 Jan; 264():116000. PubMed ID: 38056300 [TBL] [Abstract][Full Text] [Related]
58. Emergence, Transmission, and Potential Therapeutic Targets for the COVID-19 Pandemic Associated with the SARS-CoV-2. Patil AM; Göthert JR; Khairnar V Cell Physiol Biochem; 2020 Aug; 54(4):767-790. PubMed ID: 32830930 [TBL] [Abstract][Full Text] [Related]
59. Janus kinase inhibitors for the treatment of COVID-19. Kramer A; Prinz C; Fichtner F; Fischer AL; Thieme V; Grundeis F; Spagl M; Seeber C; Piechotta V; Metzendorf MI; Golinski M; Moerer O; Stephani C; Mikolajewska A; Kluge S; Stegemann M; Laudi S; Skoetz N Cochrane Database Syst Rev; 2022 Jun; 6(6):CD015209. PubMed ID: 35695334 [TBL] [Abstract][Full Text] [Related]
60. The role of disinfectants and sanitizers during COVID-19 pandemic: advantages and deleterious effects on humans and the environment. Dhama K; Patel SK; Kumar R; Masand R; Rana J; Yatoo MI; Tiwari R; Sharun K; Mohapatra RK; Natesan S; Dhawan M; Ahmad T; Emran TB; Malik YS; Harapan H Environ Sci Pollut Res Int; 2021 Jul; 28(26):34211-34228. PubMed ID: 33991301 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]